Evenementen (8)

There are so many great ways to learn and increase your CPD portfolio these days:

You can read books, listen to podcasts, watch how-to videos, attend webinars, take part in 'in-house' training, just to name a few. Why bother with the time and expense of attending BSTP events?

Here are 7 reasons why you should attend events organised by the BSTP:

  • Meet the speakers face to face and benefit from their experience
  • Networking opportunities with your peers
  • Learning in a new space to increase your knowledge on the subject matter
  • Break out of your comfort zone to learn something new
  • Invest in yourself to improve your employment opportunities
  • Increased knowledge will help when sitting examinations
  • The topics covered in some of these events are unlikely to be repeated 


The first upcoming meeting is:



Thursday 16th and Friday 17th November 2017

Knutsford, Cheshire, UK

The topic for the BSTP’s 32nd Annual Scientific Meeting is

The Pathology and Toxicity of Biologics and Biotherapeutics


The early registration fee is available until Sunday 1st October 2017 with registration closing on Sunday 22nd October 2017.


This two-day conference will provide an update of pathology and toxicity of biologics and biotherapeutics with talks from well respected national and international speakers.

The presentations will include:

  • Biologics in the pharmaceutical industry
  • Biologics to treat CNS disease
  • In vivo clinical and microscopic manifestation of unexpected ‘immune’ related effects of biologics
  • How ADA affects PK/exposure and risk assessment
  • Lung pathologies of inhaled biologics
  • Infections in NHP – how to translate to humans
  • Immunomodulation in NHP:  Practical consequences – how to run studies


The BSTP’s Annual General Meeting will be held during this event.

If your company is interested in attending as a trade exhibitor or providing sponsorship for this event, please contact the BSTP Secretariat.

Keep checking the website for more information or contact the BSTP Secretariat – Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.


Website:  http://www.bstp.org.uk/events/bstp-2017-annual-scientific-meeting/

The European Society of Toxicology In Vitro (ESTIV) in collaboration with The Belgium Toxicology Association (Bel Tox)  are pleased to announce that the ESTIV Applied in Vitro Toxicology Course  that will take place in Belvaux, Luxembourg, during 8th - 13th January 2017.

Click here for registration or more information.



In vitro toxicity methods are gaining importance, in particular as a response to a number of European legislative changes which call for more mechanistically-based decision-making and limit or even prohibit the use of animal experimentation for risk assessment purposes. Hence, there is an urgent demand for toxicologists and risk assessors to implement in vitro testing results into regulatory safety evaluation of chemicals. This course aims at meeting this ubiquitous need by training individuals who wish to start or pursue a career in this direction or to gain an update on the state-of-the-art of applied in vitro toxicology.


This course is intended for (post)doctoral students and scientists from industry, academia or regulatory agencies who recently became active in the field of in vitro toxicology. Applicants should ideally have a background in toxicology, biology, chemistry, (bio)medical sciences, pharmaceutical sciences, veterinary sciences or equivalent. Attendees are expected to be proficient in English. A maximum of 25 participants will be enrolled in the course on a first-come/first-served basis, yet priority will be given to members of ESTIV & BelTox. 


This course is organized by The European Society of Toxicology In Vitro (ESTIV) in collaboration with The Belgium Toxicology Association (BelTox) and combines cutting-edge lectures by leading experts with highly interactive group exercises. The lectures cover a broad spectrum of subjects pertinent to regulatory, screening and investigative in vitro toxicology. The group exercises consist of real-life case studies in which the participants will apply the principles of in vitro toxicology to the risk assessment of chemical substances. Course examination will be based upon presentation and discussion of the case studies. The participants will receive a certificate in the case of a positive evaluation. Furthermore, the participants will be given the opportunity to gain hands-on experience with respect to in vitro modelling.

De komende Beltox evenementen zijn toegevoegd aan de agenda:

13/10/2016    BelTox Advanced Toxicology Course on Endocrine Disruption

9/12/2016      BelTox Annual Scientific Meeting on Adverse Outcome Pathways (AOP) in toxicology and ecotoxicology

8-12/1/2017   BelTox/ESTIV course on Applied In Vitro Toxicology

Werkt REACH?
De REACH-Verordening (Registratie, Evaluatie, Autorisatie en restrictie van CHemische stoffen) is in 2007 van kracht gegaan. De verordening zorgt ervoor dat er meer bekend wordt over chemische stoffen en eist dat die chemische stoffen veilig worden gebruikt. Het belangrijkste doel van REACH is om het milieu en de gezondheid van de mens beter te beschermen tegen de risico’s die chemische stoffen kunnen opleveren. Hiervoor moeten fabrikanten en importeurs de risico's die zijn verbonden aan de stoffen die zij in de EU vervaardigen of importeren, identificeren en beheersen door middel van onder meer het registreren van hun stoffen en het bekendmaken van de risicobeperkende maatregelen via bijvoorbeeld veiligheidsinformatiebladen aan de gebruikers. Als de risico's niet kunnen worden beheerst, kunnen de autoriteiten het gebruik van stoffen op verschillende manieren beperken.
Risicoreductie is dus een belangrijke doelstelling van REACH en de vraag is of, ruim 8 jaar na invoering, geconcludeerd kan worden dat dat doel bereikt is of lijkt te worden. Dat is de belangrijke vraag die dit NVT-symposium wil beantwoorden.

12 april
RIVM, zaal T012
Antonie van Leeuwenhoeklaan 9
3720 BA Bilthoven

13.00: Ontvangst
13.20: Opening en introductie door de dagvoorzitter:
13.30: Spreker: Dirk van Aken (NVWA)
Met REACH minder risico – maar hoeveel minder? Ftalaten in speelgoed als voorbeeld
14:00: Spreker: Cees Luttikhuizen (I&M)
Vervanging van zeer zorgwekkende stoffen, van beleid naar uitvoering
14.30: Pauze
14.45: Spreker: Wim Grisnich (DSM Coating Resins BV)
Heeft REACH bijgedragen aan risicoreductie in laboratoria?
15:15: Spreker: Martijn Beekman (Bureau REACH, RIVM)
Gereedschapskist REACH en CLP; Ervaringen in het beperken van risico's.
15:45: Afsluitende discussie aan de hand van stellingen
16:15: Napraten bij een borrel



Opgave svp per e-mail bij Henriëtte van Gisbergen, Centrum Veiligheid van Stoffen en Producten, RIVM, Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.

On the 24th of March 2016, the sections on Reproductive Toxicology and Pharmaceutical Toxicology will organize the spring symposium entitled:

“Pediatric drug development: a field in maturation”

The invited speakers will share the latest insights on risk assessment of pediatric drugs from various perspectives. From nonclinical studies to clinical practice, improvement in dosage forms and regimens using modeling techniques, and reporting of adverse drug reactions in children. The symposium will be held at the Radboud University Medical Center in Nijmegen.

The registration fee for this meeting is €15 for NVT members and €20 for non-members, due (in cash) at the registration desk at the day of the meeting. This includes coffee, lunch and drinks at the concluding reception. Registration deadline is 9th of March 2016. To attend this meeting you must be registered by sending an e-mail to Wendy van Eldijk, Dit e-mailadres wordt beveiligd tegen spambots. JavaScript dient ingeschakeld te zijn om het te bekijken.. She will also be able to provide you with the detailed program and further directions to the venue.
We hope the program meets your interest and to welcome many of you on the 24th of March 2016!

On behalf of the organizing committees,
Section of Reproduction toxicology: Liesbeth Heijink, Sjors Schulpen, Manon Beekhuijzen, André Wolterbeek
Section of Pharmaceutical toxicology: Leon van Aerts, Peter Theunissen, Suzanne Heemskerk, Lieke Peters, Cathaline den Besten, Jan Commandeur, Bob van de Water

9-13 Oktober 2016 - International Society of Exposure Sciences (ISES) Annual Meeting, Jaarbeurs, Utrecht. www.ises2016.org/ 

Let op: de deadline voor het insturen van abstracts is 13 maart a.s. en aanmeldingen voor deelname worden verwerkt tot 15 augustus!

Occupational exposure limits of dangerous substances have yet been solely set for the inhalation of workroom air. Where studies have shown that dermal exposure could cause systemic effects a skin notation is added as an alert to the OEL of the chemical.

With the introduction of the EU REACH-directives separate exposure limits were derived for dermal exposure such as the DNELdermal, local or the DNELdermal, systemic. Has this new attention led to new tools to assess dermal exposure in the workplace? That is the subject of this mini-symposium. All presentations will be in English.

Click here for the programme


September 2017
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
Ga naar boven